Electrochemotherapy: From basics to new clinical applications
Join us for an exciting CIRSE Webinar that explores the clinical potential of reversible electroporation combined with the cytotoxic drug bleomycin as a cutting-edge drug delivery method. Explore how electrochemotherapy, the combination of these two techniques, is transforming the treatment of tumour nodules in challenging locations such as the liver, pancreas, musculoskeletal system, and even vertebral metastases causing spinal cord compression. Additionally, the session will introduce bleomycin electrosclerotherapy (BEST), a novel application targeting vascular abnormalities. With its minimal side effects and success in tackling hard-to-treat conditions, electrochemotherapy offers a fresh, promising option for interventional radiologists looking to expand their therapeutic toolkit where conventional treatments can be ineffective.
Learning objectives
- To learn about reversible electroporation as a drug delivery approach.
- To gain interest in the combination of reversible electroporation and the cytotoxic drug bleomycin.
- To learn about BEST, bleomycin electrosclerotherapy, which is an application of the combination of bleomycin and reversible electroporation for the treatment of vascular abnormalities.
- To learn about electrochemotherapy (the combination of reversible electroporation and bleomycin) for the percutaneous treatment of tumour nodules in the liver and pancreas.
- To discuss electrochemotherapy (the combination of reversible electroporation and bleomycin) for the treatment of musculoskeletal tumour nodules.
- To learn about electrochemotherapy (the combination of reversible electroporation and bleomycin) for the treatment of spinal cord compressing vertebral metastases
Programme
Introduction by the moderator
Principle of electrochemotherapy and the interest of using reversible electroporation
Applications for vascular malformations
Application in oncology for pancreas and liver cancer treatment
Application in oncology for musculoskeletal tumours treatment
Application for vertebral metastases
Discussion and closing
Faculty
Moderators
Frederic Deschamps (Villejuif/FR)
Lluis M. Mir (Villejuif/FR)
Speakers
Speakers will be announced soon.
Join free of charge!
Access to this webinar is available free of charge to all interested parties. All you need is your CIRSE login details. Don’t have a CIRSE account yet? Not to worry! It only takes two minutes to set up a new account which will enable you to register.